| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/08/2004 | US20040005354 Oral trimethobenzamide formulations and methods |
| 01/08/2004 | US20040005325 Helicobacter felis vaccine |
| 01/08/2004 | US20040005318 Method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided. |
| 01/08/2004 | US20040005316 Use of HMG fragments as anti-inflammatory agents |
| 01/08/2004 | US20040005305 Nutritional composition for treating an immune condition |
| 01/08/2004 | US20040005303 In vivo induction for enhanced function of isolated hepatocytes |
| 01/08/2004 | US20040005298 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 01/08/2004 | DE10227793A1 Stabilisierte Cholinascorbat enthaltende Zusammensetzung Stabilized choline-containing composition |
| 01/08/2004 | DE10227269A1 Thiazolderivate Thiazole derivatives |
| 01/08/2004 | DE10226494A1 Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen Film form mucoadhesive dosage forms for administration of cannabis drugs |
| 01/08/2004 | DE10224844A1 Nicht-peptidische BRS-3-Agonisten Non-peptidic BRS-3 agonist |
| 01/08/2004 | DE10057290B4 Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten To be administered enterally supplement for parenteral nutrition or partial enteral / oral nutrition in critically ill patients, chronically ill and malnourished |
| 01/08/2004 | CA2744893A1 Aryl carbonyl derivatives as glucokinase activators |
| 01/08/2004 | CA2493854A1 Phosphodiesterase inhibitor |
| 01/08/2004 | CA2493646A1 Caspase inhibitors and uses thereof |
| 01/08/2004 | CA2492066A1 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 01/08/2004 | CA2491156A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2491118A1 A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
| 01/08/2004 | CA2490950A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490129A1 Compositions and methods comprising protein activated receptor antagonists |
| 01/08/2004 | CA2490016A1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/08/2004 | CA2489560A1 Substituted quinoline ccr5 receptor antagonists |
| 01/08/2004 | CA2489552A1 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 01/08/2004 | CA2489376A1 Methods of organ regeneration |
| 01/08/2004 | CA2488703A1 Food and beverage product for stimulating gastrointestinal mobility |
| 01/08/2004 | CA2488526A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | CA2488039A1 A pharmaceutical composition for preventive and/or therapeutic treatment of constipation and symptom resulting from constipation |
| 01/07/2004 | EP1378510A1 Triazaspiro 5.5]undecane derivatives and drugs containing the same as the active ingredient |
| 01/07/2004 | EP1378236A1 Agents against stress-induced diseases drugs |
| 01/07/2004 | EP1377610A2 Osteoprotegerin in milk |
| 01/07/2004 | EP1377609A2 Mhc molecule constructs and their uses for diagnosis and therapy |
| 01/07/2004 | EP1377593A2 2-amino-propanol derivatives |
| 01/07/2004 | EP1377587A1 Protein phosphate inhibitors |
| 01/07/2004 | EP1377583A1 Novel tricyclic hydroxy carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377576A2 Pyridine derivatives |
| 01/07/2004 | EP1377573A2 Pyrazolopyridine derivatives |
| 01/07/2004 | EP1377572A1 Isoxaxole derivatives as inhibitors of src and other protein kinases |
| 01/07/2004 | EP1377569A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 01/07/2004 | EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 01/07/2004 | EP1377565A1 Tetrahydropyran derivatives as neurokinin receptor antagonists |
| 01/07/2004 | EP1377560A1 Piperazine derivatives as tachykinin antagonists |
| 01/07/2004 | EP1377559A2 Rxr activating molecules |
| 01/07/2004 | EP1377558A1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists |
| 01/07/2004 | EP1377555A1 Novel compounds |
| 01/07/2004 | EP1377550A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 01/07/2004 | EP1377540A1 INHIBITORS OF INTEGRIN AvB6 |
| 01/07/2004 | EP1377291A2 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 01/07/2004 | EP1377288A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method |
| 01/07/2004 | EP1377276A2 Timed pulse release composition |
| 01/07/2004 | EP1377164A1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 01/07/2004 | EP1294388B1 Extracts from sophora species, method for producing the same and their use |
| 01/07/2004 | EP1289997B1 Macrolides |
| 01/07/2004 | EP1175417B1 Substituted benzolactam compounds |
| 01/07/2004 | EP1056733B1 Histamine h3 receptor ligands |
| 01/07/2004 | EP0661992B1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 01/07/2004 | CN1466591A Nucleoside derivatives |
| 01/07/2004 | CN1466586A Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 01/07/2004 | CN1466576A Quinolne-(C=O)-CD1, tri-and tetrapeptide) derivatives as caspase inhibitors |
| 01/07/2004 | CN1466573A 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 01/07/2004 | CN1466567A Substituted 1-aminobutan-3-01 derivatives |
| 01/07/2004 | CN1466465A Preventives or remedies for obesity or fatty liver |
| 01/07/2004 | CN1466462A Method for producing agrimonia extract with improved activity against hepatitis Bvirus and pharmaceutical and flood compositions containing said extract |
| 01/07/2004 | CN1466459A 营养组合物 The nutritional composition |
| 01/07/2004 | CN1466451A Ion-strength independent sustained release pharmacetuical formulation |
| 01/07/2004 | CN1465693A Ostrica bone medicinal liquor and preparation method thereof |
| 01/07/2004 | CN1465392A Violet stem privet leaf ultrafine powder lozenge and productive process thereof |
| 01/07/2004 | CN1465391A Prescription for treating duodenal ulcer and gastric ulcer |
| 01/07/2004 | CN1465381A Medicine for regutating the flow of qi and promoting digestion |
| 01/07/2004 | CN1465378A Baicaoganfukang medicine for treating hepatophathy |
| 01/07/2004 | CN1465375A Fresh ginger mouth-sucking candy for eliminating ozostomia and preparation method thereof |
| 01/07/2004 | CN1465372A Umbilicus plaster for curing stomach-ache |
| 01/07/2004 | CN1465369A Chinese medicine Wuxingsan powder and its preparation method |
| 01/07/2004 | CN1465363A Medicine for treating constipation and preparation method thereof |
| 01/07/2004 | CN1465362A Ampelopsis grossedentata lozenge and preparation method thereof |
| 01/07/2004 | CN1465360A Medicine for treating hepatopathy |
| 01/07/2004 | CN1465357A Chinese patent drug for treating chronic gastritis and chronic gastric ulcer |
| 01/07/2004 | CN1465350A Toad skin preparation and productive process thereof |
| 01/07/2004 | CN1465341A Arginine acetate oral preparation and clinical application thereof |
| 01/07/2004 | CN1133636C Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| 01/07/2004 | CN1133622C Ureidopiperidine derivatives as selective human NK3 receptor antagonists |
| 01/07/2004 | CN1133457C Chinese patent medicine for treating intractable and habitual constipation |
| 01/07/2004 | CN1133452C Chunren liver recovering capsule |
| 01/07/2004 | CN1133447C Pure Chinese medicine prepn. for fast strengthening yang and tonifying kidney |
| 01/07/2004 | CN1133440C Stomach and kidney disease treating medicine powder |
| 01/07/2004 | CN1133434C Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/06/2004 | US6673897 Inhibitors of NF-κB Activation |
| 01/06/2004 | US6673798 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 01/06/2004 | US6673796 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/06/2004 | US6673795 Pyrimidine, pyrazine and triazane derivatives |
| 01/06/2004 | US6673794 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 01/06/2004 | US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 01/06/2004 | US6673555 Methods of using SCAP antagonists |
| 01/06/2004 | US6673379 Use of non-alkalized cocoa solids in a drink |
| 01/06/2004 | US6673368 Colonic motor dysfunction remedies comprising aminothiazole derivatives as active ingredients |
| 01/06/2004 | CA2253870C Inhibition of matrix metalloproteases by substituted phenalkyl compounds |
| 01/06/2004 | CA2086681C Growth promoting agent derived from milk |
| 01/02/2004 | EP1375516A2 Method of production of a recombinant polypeptide of the LSR receptor |
| 01/02/2004 | EP1375497A1 Magnesium salt of s-omeprazole |
| 01/02/2004 | EP1375484A1 Carboxylic acids |